Sonoma Pharmaceuticals SNOAW 深 沪
等待开盘 05-21 09:30:00 美东时间
0.002
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.002
- 总市值 981.00万
- 52周最高 0.05
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.001
- 委 比 0.00%
- 总股本 49.05亿
- 历史最高 0.788
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.001
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sonoma Pharmaceuticals shares are trading higher after the company entered an agreement with Dawson James Securities to sell 2,962,962 units at $1.35 per unit.
Sonoma Pharmaceuticals shares are trading higher after the company entered an a...
05-02 02:20
What's Going On With Sonoma Pharma Stock Monday?
Sonoma Pharmaceuticals (SNOA) shares slide following a $4M public offering priced at $1.35. Get the latest stock news here.
04-27 21:54
Sonoma Pharmaceuticals Prices Offering Of 2,962,963 Shares And Accompanying Warrants At $1.35 Per Unit
Sonoma Pharmaceuticals Prices Offering Of 2,962,963 Shares And Accompanying War...
04-24 21:33
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
Sonoma Pharmaceuticals Signs U.S. Microcyn Supply Agreement
Sonoma Pharmaceuticals ( ($SNOA) ) has provided an update. On April 8, 2026, So...
04-09 21:34
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS
Sonoma Pharmaceuticals jumps over 16% in after-hours trading following the U.S. retail launch of its burn relief hydrogel in CVS and Walmart stores.
03-27 14:35
Sonoma Pharmaceuticals Q3 EPS $(0.48) Misses $(0.31) Estimate, Sales $4.349M Beat $4.326M Estimate
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.48) per share which missed the analyst consensus estimate of $(0.31) by 54.84 percent. This is a 23.81 percent increase over losses of $(0.63) per
02-11 06:25
Sonoma Pharmaceuticals Q3 revenue rises 22%
Sonoma Pharmaceuticals Q3 revenue rises 22% Overview Healthcare product maker's fiscal Q3 revenue rose 22% yr/yr Net loss and EBITDAS loss decreased for fiscal Q3 compared to last year Company expanded distribution channels and strengthened leadership Outlook Sonoma Pharmaceuticals did not provide s
02-11 05:18
BRIEF-Sonoma Pharmaceuticals Q3 Net Income USD -600 Thousand
BRIEF-Sonoma Pharmaceuticals Q3 Net Income USD -600 Thousand Feb 10 (Reuters) - Sonoma Pharmaceuticals Q3 revenue USD 4.3 million. Q3 gross profit USD 1.6 million Q3 operating expenses USD 2.3 million
02-11 05:11
Sonoma Pharma Europe revenue up 31% to USD X in Q3
Sonoma Pharma Europe revenue up 31% to USD X in Q3 Sonoma Pharmaceuticals Inc. reported its financial results for the quarter ended December 31, 2025. The company highlighted a 31 percent increase in revenues from Europe, attributed to higher demand for its products. Revenues in Asia grew 38 percent
02-11 05:02
